2017
DOI: 10.1016/j.msec.2016.12.055
|View full text |Cite
|
Sign up to set email alerts
|

The role of nanoparticles in the albumin-cytarabine and albumin-methotrexate interactions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
6
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 13 publications
(9 citation statements)
references
References 37 publications
3
6
0
Order By: Relevance
“…However, when the pH value of 0.9% saline decreases from 7.0 to 4.0, the release rate of loaded PTX increases from 37.61 to 65.56% in 96 h, which implies that PTX loaded on CA-CSNPs would have a faster release rate when it is transported to the vicinity of tumor cells because of the slightly acidic environment of tumor cells, which is consistent with the micro acid environment tested in vitro. As can be seen in Table S3, the release kinetics show that PTX release from CA-CSNPs was consistent with the Ritger-Peppas release kinetics (Equation ( 9)), and the drug release factor (n) was 0.32 when the pH value of 0.9% normal saline was 7.0, which suggests that the mechanism of PTX release on CA-CSNPs should be Fick diffusion rather than dissolution desorption [46], and indicates that PTX had already diffused into the carrier interior in the loading process of PTX due to the most amorphous structure of CA-CSNPs. Therefore, once the drug carrier is in the bloodstream, CA-CSNPs will effectively avoid PTX As can be seen in Table S3, the release kinetics show that PTX release from CA-CSNPs was consistent with the Ritger-Peppas release kinetics (Equation ( 9)), and the drug release factor (n) was 0.32 when the pH value of 0.9% normal saline was 7.0, which suggests that the mechanism of PTX release on CA-CSNPs should be Fick diffusion rather than dissolution desorption [46], and indicates that PTX had already diffused into the carrier interior in the loading process of PTX due to the most amorphous structure of CA-CSNPs.…”
Section: Drug Release Analysissupporting
confidence: 66%
See 1 more Smart Citation
“…However, when the pH value of 0.9% saline decreases from 7.0 to 4.0, the release rate of loaded PTX increases from 37.61 to 65.56% in 96 h, which implies that PTX loaded on CA-CSNPs would have a faster release rate when it is transported to the vicinity of tumor cells because of the slightly acidic environment of tumor cells, which is consistent with the micro acid environment tested in vitro. As can be seen in Table S3, the release kinetics show that PTX release from CA-CSNPs was consistent with the Ritger-Peppas release kinetics (Equation ( 9)), and the drug release factor (n) was 0.32 when the pH value of 0.9% normal saline was 7.0, which suggests that the mechanism of PTX release on CA-CSNPs should be Fick diffusion rather than dissolution desorption [46], and indicates that PTX had already diffused into the carrier interior in the loading process of PTX due to the most amorphous structure of CA-CSNPs. Therefore, once the drug carrier is in the bloodstream, CA-CSNPs will effectively avoid PTX As can be seen in Table S3, the release kinetics show that PTX release from CA-CSNPs was consistent with the Ritger-Peppas release kinetics (Equation ( 9)), and the drug release factor (n) was 0.32 when the pH value of 0.9% normal saline was 7.0, which suggests that the mechanism of PTX release on CA-CSNPs should be Fick diffusion rather than dissolution desorption [46], and indicates that PTX had already diffused into the carrier interior in the loading process of PTX due to the most amorphous structure of CA-CSNPs.…”
Section: Drug Release Analysissupporting
confidence: 66%
“…As can be seen in Table S3, the release kinetics show that PTX release from CA-CSNPs was consistent with the Ritger-Peppas release kinetics (Equation ( 9)), and the drug release factor (n) was 0.32 when the pH value of 0.9% normal saline was 7.0, which suggests that the mechanism of PTX release on CA-CSNPs should be Fick diffusion rather than dissolution desorption [46], and indicates that PTX had already diffused into the carrier interior in the loading process of PTX due to the most amorphous structure of CA-CSNPs. Therefore, once the drug carrier is in the bloodstream, CA-CSNPs will effectively avoid PTX As can be seen in Table S3, the release kinetics show that PTX release from CA-CSNPs was consistent with the Ritger-Peppas release kinetics (Equation ( 9)), and the drug release factor (n) was 0.32 when the pH value of 0.9% normal saline was 7.0, which suggests that the mechanism of PTX release on CA-CSNPs should be Fick diffusion rather than dissolution desorption [46], and indicates that PTX had already diffused into the carrier interior in the loading process of PTX due to the most amorphous structure of CA-CSNPs. Therefore, once the drug carrier is in the bloodstream, CA-CSNPs will effectively avoid PTX binding with blood protein to protect the physiological activity of PTX.…”
Section: Drug Release Analysissupporting
confidence: 66%
“…The decrease in the degree of encapsulated caffeine with the increase in the caffeine amount bound to protein has also been reported by Y. Guo et al [ 43 ] The calculated degree of encapsulated caffeine in the liposomes was 84.8% (Equation 1), which was high according to the published literature. [ 44 ]…”
Section: Results and Disscussionmentioning
confidence: 99%
“…The REV method was described by Papahadjopoulos [19]. The modification of this method consisted of replacing the ultrasonic dispersion of the aqueous phase in the organic phase with mechanical dispersion that allows complete conversion of the phospholipids to the liposomes [20].…”
Section: Liposome Preparationmentioning
confidence: 99%